Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

BACKGROUND: Accumulating evidence suggests glucagon-like peptide-1 (GLP-1) exerts cardioprotective effects in animal models of myocardial infarction (MI). We hypothesized that chronic treatment with GLP-1 or the exenatide analog AC3174 would improve cardiac function, cardiac remodeling, insulin sens...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Que, Anderson, Christen, Broyde, Anatoly, Polizzi, Clara, Fernandez, Rayne, Baron, Alain, Parkes, David G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996354/
https://www.ncbi.nlm.nih.gov/pubmed/21080957
http://dx.doi.org/10.1186/1475-2840-9-76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996354/
https://www.ncbi.nlm.nih.gov/pubmed/21080957
http://dx.doi.org/10.1186/1475-2840-9-76

Ejemplares similares